Anti-N-methyl-D-aspartate receptor encephalitis is a rare autoimmune disorder that involves N-methyl-D-aspartate (NMDA) receptors. It is the most common autoimmune encephalitis, and early detection and treatment are crucial for morbidity-free recovery. Distinguishing this disorder from a primary psychiatric illness is quite challenging as this disorder classically presents with psychiatric manifestations that often resemble schizophrenic psychosis. Therefore, this review intended to scope the psychiatric manifestations this disorder could present with and dissect how they differ from primary psychiatric disorders. A PubMed database search was done. The results yielded were analyzed; eventually, 50 papers were used to review the different signs and symptoms the disease can present with, including common and rare disease presentations. Diagnostic challenges and helpful clinical clues to recognize the disorder were reviewed as well.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225684PMC
http://dx.doi.org/10.7759/cureus.15188DOI Listing

Publication Analysis

Top Keywords

anti-n-methyl-d-aspartate receptor
8
receptor encephalitis
8
primary psychiatric
8
psychiatric manifestations
8
psychiatric
5
disorder
5
encephalitis detailed
4
detailed review
4
review psychiatric
4
psychiatric presentations
4

Similar Publications

Objective: The aim of this study was to analyze the clinical characteristics of adult patients with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis combined with anti-myelin oligodendrocyte glycoprotein (MOG) antibodies.

Methods: This was a non-randomized controlled study. Clinical data were collected from 17 patients with anti-NMDAR encephalitis combined with anti-MOG antibodies admitted to Xuanwu Hospital, Capital Medical University, from January 2020 to August 2024.

View Article and Find Full Text PDF

Patients with anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis, often present with severe psychiatric symptoms, yet the neuropathological mechanisms underlying their cognitive deficits remain insufficiently understood. In this study, we constructed an animal model using anti-NMDAR IgG purified from the serum of patients with anti-NMDAR encephalitis, and we used IgG obtained from healthy individuals as a control. Daily administration of anti-NMDAR IgG into the medial prefrontal cortex (mPFC) of mice for 7 days resulted in cognitive impairments resembling clinical symptoms, which spontaneously resolved 30 days after discontinuing the injections.

View Article and Find Full Text PDF

Anti-N-methyl-d-aspartate receptor encephalitis (NMDARE) is an autoimmune disorder with a clinical presentation that overlaps with that of a myriad of neuropsychiatric conditions. Delays in diagnosis have been linked to long-term complications that affect a patient's quality of life. A 60-year-old female patient with a medical history of emphysema with chronic respiratory failure, hypertension, diabetes, morbid obesity, and hyperlipidemia presented to the hospital after she was found confused at home with limited verbal output, raising concerns for cerebrovascular events or toxic metabolic encephalitis.

View Article and Find Full Text PDF

Anti-N-methyl-D-aspartate (NMDA) receptor NMDAR) encephalitis is a relatively recent condition, classified as an immune-mediated disorder characterized by a complex neuropsychiatric syndrome and the presence of anti-GluN1 subunit antibodies against the NMDA receptor in cerebrospinal fluid (CSF). Although it is a rare disease, studies have identified it as one of the most common causes of autoimmune encephalitis. The pathophysiology of this condition is not yet fully understood, especially regarding its association with ovarian teratomas and other neoplasms.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!